Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
1.
BDJ Open ; 10(1): 47, 2024 Jun 11.
Article in English | MEDLINE | ID: mdl-38862495

ABSTRACT

AIM: A healthy diet could help to prevent both oral and systemic diseases, with dentists and nutritionists supplementing their skills. The dental setting, where patients periodically refer to seeking oral health care, represents a powerful opportunity for nutritional counselling. To the best of our knowledge, no study is available on patients' attitudes towards dietary counselling in the dental setting. This cross-sectional study investigates patients' attitude towards receiving nutritional support within the dental setting and it elucidates whether a transdisciplinary approach would be well accepted. MATERIALS AND METHODS: A questionnaire was administered to patients attending three different clinics: a private clinic, a hospital dental clinic of the national healthcare system and the private dental practice within the same hospital. RESULTS: Three hundred thirteen questionnaires were collected. Most dental patients acknowledged receiving nutritional advice from both dentists and nutritionists. The nutritionist within the dental setting was positively perceived, providing useful advice to prevent oral and systemic diseases and also drawing up a diet with periodic follow-ups. DISCUSSION AND CONCLUSION: These findings support the positive attitude of patients towards receiving nutritional counselling within the dental setting. The dental clinics can be pivotal in oral and systemic disease screening and prevention and a multidisciplinary approach is highly encouraged.

3.
Eur J Paediatr Dent ; 22(2): 159-162, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34238009

ABSTRACT

AIM: Localised juvenile spongiotic gingival hyperplasia (LJSGH) is a benign lesion occurring in young patients as gingival erythema and overgrowth, typically localised on gingiva of maxillary incisors. The aim of this work is to report a case of LJSGH where complete spontaneous regression was achieved together with a review of the literature on the topic. CASE REPORT: An 8-year-old girl was referred for a gingival painless lesion, which had appeared spontaneously one year before and was refractory to periodontal treatment. Intraoral examination showed a well-defined, red gingival overgrowth involving the left maxillary central incisor, without involving the marginal gingiva. The clinical diagnosis of LJSGH was made, due to the pathognomonic aspect. The patient was periodically recalled for 43 months; at the last visit, the lesion was spontaneously resolved. RESULTS: LJSGH is not plaque-related and not responsive to periodontal treatment. Surgical removal of the lesions correlates with high recurrence, while spontaneous resolution over time has been hardly demonstrated. CONCLUSION: Follow-up of LJSGH may be an option of care, alternative to surgery, in selected cases.


Subject(s)
Gingival Hyperplasia , Child , Dental Care , Female , Gingiva , Gingival Hyperplasia/surgery , Humans , Incisor
4.
J Endocrinol Invest ; 44(5): 905-919, 2021 May.
Article in English | MEDLINE | ID: mdl-32926396

ABSTRACT

CONTEXT AND PURPOSE: Hypocalcemia and low parathyroid hormone levels have been commonly suggested as factors able to induce central nervous system disturbances. However, evidences on the occurrence of cognitive impairment are limited or underestimated. The aim of this review is, therefore, to systematically summarize the available evidence concerning the occurrence of cognitive impairment among subjects suffering from idiopathic or secondary hypoparathyroidism. METHODS: A systematic selection of the available literature was performed by searching the online databases PubMed, Scopus and Web of Knowledge. RESULTS: The present systematic review included sixteen case report articles and one cross-sectional controlled study. Case reports were the most representative literature sources and involved ten women and seven men. The presence of cognitive impairment was mostly discussed in association with idiopathic hypoparathyroidism (HPT); five articles described the occurrence of cognitive impairment following postsurgical HPT. The case-controlled study reported a significant presence of peculiar cognitive deficits (e.g. reduced inhibitory control, impairment in visuo-spatial functioning among, and psychomotor retardation) among HPT subjects compared to healthy controls, with serum total calcium and its product with phosphorus as independent predictors of neuropsychological dysfunctions. CONCLUSION: Even though mostly based on single case reports, the presence of neuropsychological dysfunctions in the context of HPT appears to be a consistent core finding.


Subject(s)
Cognitive Dysfunction , Hypoparathyroidism , Cognitive Dysfunction/blood , Cognitive Dysfunction/diagnosis , Cognitive Dysfunction/physiopathology , Humans , Hypocalcemia/diagnosis , Hypocalcemia/etiology , Hypoparathyroidism/blood , Hypoparathyroidism/etiology , Hypoparathyroidism/psychology , Neuropsychological Tests , Parathyroid Hormone/analysis
5.
Trials ; 21(1): 711, 2020 Aug 12.
Article in English | MEDLINE | ID: mdl-32787910

ABSTRACT

BACKGROUND: A core outcome set (COS) represents the agreed minimum set of domains and measurement instruments that should be measured and reported in any clinical trial for a given condition. In BMS randomized controlled trials (RCTs), the outcomes identified in the existing literature regarding the efficacy of therapeutic interventions are numerous and diverse. Although the standardized IMMPACT core outcome domains has been developed for measurement of outcomes in chronic pain RCTs, no BMS-specific COS have been adopted and validated. With the evolving landscape of BMS management end points and the development of new therapies, a consensus on a COS for use in future BMS trials is paramount to reduce heterogeneity in outcome reporting. The aim of this study was to reach a consensus for adopting the standardized Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) outcome domains, and their tools of assessment, for burning mouth syndrome (BMS) clinical trials and clinical practice. METHODS: A BMS-specific COS will be developed using the method recommended by the Core Outcome Measures in Effective Trials (COMET) initiative (Registration: http://www.comet-initiative.org/studies/details/1357 ). Selection of questionnaire outcome measures was informed by the IMMPACT consensus and previous systematic review of RCTs in BMS conducted by the consortium. An international group of clinicians and researchers will be invited to participate in several rounds of a Delphi survey. A consensus meeting will be held with the objective of ratifying the outcomes for inclusion in the COS. A finalized COS explanatory document will be drafted, including all outcomes and measurements as determined by the Delphi rounds and consensus meeting. DISCUSSION: A COS for the management of BMS will improve the quality of future RCTs, reduce outcome reporting heterogeneity, and facilitate more vigorous data synthesis of management interventions for systematic reviews and meta-analysis. This would ensure enhanced quality evidence for clinical management of the condition.


Subject(s)
Burning Mouth Syndrome , Research Design , Burning Mouth Syndrome/diagnosis , Burning Mouth Syndrome/therapy , Delphi Technique , Endpoint Determination , Humans , Meta-Analysis as Topic , Outcome Assessment, Health Care , Randomized Controlled Trials as Topic , Surveys and Questionnaires , Systematic Reviews as Topic , Treatment Outcome
6.
Oral Dis ; 24(4): 638-649, 2018 May.
Article in English | MEDLINE | ID: mdl-29156085

ABSTRACT

OBJECTIVES: To investigate the quality of sleep and the psychological profiles of a large cohort of Italian patients with burning mouth syndrome (BMS) and to clarify the relationships between these variables and pain. METHODS: In this case-control study, 200 patients with BMS vs an equal number of age- and sex-matched healthy controls, recruited in 10 universities, were enrolled. The Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), Hamilton Rating Scale for Depression (HAM-D), Hamilton Rating Scale for Anxiety (HAM-A), Numeric Pain Intensity Scale (NRS) and Total Pain Rating Index (T-PRI) were administered. Descriptive statistics, including the Mann-Whitney U test and hierarchical multiple linear regression analysis, were used. RESULTS: Poor sleep quality (PSQI ≥ 5) was present in 78.8% (160) patients with BMS. BMS patients had statistically higher scores in all items of the PSQI and ESS than the healthy controls (p < .001). A depressed mood and anxiety correlated positively with sleep disturbance. The Pearson correlations were 0.570 for the PSQI vs HAM-D (p < .001) and 0.549 for the PSQI vs HAM-A (p < .001). Pain intensity (NRS) poorly correlated to sleep quality; the Pearson correlation was 0.162 for the PSQI vs NRS (p = .021). CONCLUSIONS: The BMS patients showed a poor sleep quality, anxiety and depression, as compared with the controls, highlighting the relationships between oral burning, sleep and mood.


Subject(s)
Burning Mouth Syndrome/epidemiology , Sleep Wake Disorders/epidemiology , Adult , Aged , Anxiety/epidemiology , Burning Mouth Syndrome/complications , Burning Mouth Syndrome/psychology , Case-Control Studies , Depression/epidemiology , Female , Humans , Male , Middle Aged , Pain/etiology , Prevalence , Sleep
7.
Micron ; 79: 36-45, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26369496

ABSTRACT

Balclutha brevis Lindberg 1954 is an allochthonous leafhopper infesting an invasive grass, Pennisetum setaceum, in Sicily and in mainland Europe; therefore, this species could compete with populations of native species, thus contributing to the loss of biodiversity. Considering the ecological implications of B. brevis, investigations on all its biological aspects represent, therefore, a premise for further studies in applied sciences. Based on the lacking ultrastructural data about the reproductive systems of the Auchenorrhyncha, we carried out morphostructural investigations on the male reproductive system of B. brevis. Further, a first report of DNA barcoding analysis (amplification and sequencing of Cytochrome Oxidase I gene) has also been performed to characterize B. brevis compared to other congeneric species. From a morphological point of view, the male reproductive system of B. brevis has an organization comparable to the general anatomical features of most of the Auchenorrhyncha species; however, comparing our data with those concerning the different groups of Cicadomorpha, some considerations are discussed. As for the histological and ultrastructural investigations, our results show a secretory activity of the various examined structures, mainly in the lateral ejaculatory ducts and in the accessory glands. The latter, in particular, show morphostructural differences comparing the distal tract to the proximal one; moreover, the histochemical techniques showed the possible presence of a lipid component in the peculiar cytoplasmic granules found in the gland cells. The significance of these findings in the accessory glands is discussed. Finally, the ultrastructural features found in the seminal vesicles are different from those of the lateral ejaculatory ducts and are indicative of the different roles played by these structures in the organization of the spermatozoa bundles.


Subject(s)
DNA Barcoding, Taxonomic/methods , Hemiptera/anatomy & histology , Hemiptera/classification , Animals , Ejaculatory Ducts/anatomy & histology , Ejaculatory Ducts/ultrastructure , Electron Transport Complex IV/genetics , Hemiptera/genetics , Male , Microscopy, Electron, Transmission/methods , Seminal Vesicles/anatomy & histology , Seminal Vesicles/ultrastructure , Spermatozoa/ultrastructure , Urogenital System/anatomy & histology , Urogenital System/ultrastructure
8.
Aquat Toxicol ; 167: 124-33, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26281774

ABSTRACT

In photosynthetic organisms sulfate constitutes the main sulfur source for the biosynthesis of GSH and its precursor Cys. Hence, sulfur availability can modulate the capacity to cope with environmental stresses, a phenomenon known as SIR/SED (Sulfur Induced Resistance or Sulfur Enhanced Defence). Since chromate may compete for sulfate transport into the cells, in this study chromium accumulation and tolerance were investigated in relation to sulfur availability in two strains of the unicellular green alga Scenedesmus acutus with different Cr-sensitivities. Paradoxically, sulfur deprivation has been demonstrated to induce a transient increase of Cr-tolerance in both strains. Sulfur deprivation is known to enhance the sulfate uptake/assimilation pathway leading to important consequences on Cr-tolerance: (i) reduced chromate uptake due to the induction of high affinity sulfate transporters (ii) higher production of cysteine and GSH which can play a role both through the formation of unsoluble complexes and their sequestration in inert compartments. To investigate the role of the above mentioned mechanisms, Cr accumulation in total cells and in different cell compartments (cell wall, membranes, soluble and miscellaneous fractions) was analyzed in both sulfur-starved and unstarved cells. Both strains mainly accumulated chromium in the soluble fraction, but the uptake was higher in the wild-type. In this type a short period of sulfur starvation before Cr(VI) treatment lowered chromium accumulation to the level observed in the unstarved Cr-tolerant strain, in which Cr uptake seems instead less influenced by S-starvation, since no significant decrease was observed. The increase in Cr-tolerance following S-starvation seems thus to rely on different mechanisms in the two strains, suggesting the induction of a mechanism constitutively active in the Cr-tolerant strain, maybe a high affinity sulfate transporter also in the wild-type. Changes observed in the cell wall and membrane fractions suggest a strong involvement of these compartments in Cr-tolerance increase following S-starvation.


Subject(s)
Chromium/toxicity , Scenedesmus/drug effects , Sulfur/metabolism , Cysteine/metabolism , Drug Tolerance , Scenedesmus/metabolism , Species Specificity , Sulfates/metabolism , Water Pollutants, Chemical/toxicity
9.
Oral Dis ; 20(5): 466-72, 2014 Jul.
Article in English | MEDLINE | ID: mdl-23837876

ABSTRACT

OBJECTIVE: This study aimed at evaluating from a morphological point of view the effects of alendronate (ALN), a widely used nitrogen-containing bisphosphonate for the chronic treatment of osteoporosis, on the oral epithelium of healthy keratinized human oral mucosa. Bisphosphonate-related osteonecrosis of the jaw is a well-known severe consequence, but the effects during chronic therapy on the oral soft tissues are still matter of debate. MATERIALS AND METHODS: Six women over 60 year-old undergoing treatment of osteoporosis with 70 mg per week of oral ALN (lasting at least 2 years) were recruited and compared with a gender and age-matched group (n = 6). Proliferation, apoptosis, intercellular adhesion and terminal differentiation (TD) were investigated by immunofluorescence. In parallel, ultrastructural analysis was carried out. RESULTS: By immunofluorescence, a statistically significant decrease in keratinocyte proliferation was detected in the oral epithelium of the ALN group without any sign of apoptosis, but accompanied by a reduction in desmoglein 1 and keratin 10 expressions. In the uppermost layers of the oral epithelium of the ALN group, thin desmosomes were visible by transmission electron microscopy. CONCLUSION: Our results show that epithelial adhesion, TD and proliferation are affected by ALN therapeutic doses in clinically healthy human oral mucosa.


Subject(s)
Alendronate/pharmacology , Bone Density Conservation Agents/pharmacology , Mouth Mucosa/drug effects , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Epithelial Cells/drug effects , Epithelium/drug effects , Female , Fluorescent Antibody Technique , Humans , Microscopy, Electron, Transmission , Middle Aged
10.
Ann Stomatol (Roma) ; 4(Suppl 2): 6, 2013.
Article in English | MEDLINE | ID: mdl-24353761
11.
Ann Stomatol (Roma) ; 4(Suppl 2): 40-1, 2013.
Article in English | MEDLINE | ID: mdl-24353814
12.
Ann Stomatol (Roma) ; 4(Suppl 2): 41, 2013.
Article in English | MEDLINE | ID: mdl-24353815
13.
Ann Stomatol (Roma) ; 4(Suppl 2): 46, 2013.
Article in English | MEDLINE | ID: mdl-24353823
14.
Minerva Stomatol ; 62(5): 163-81, 2013 May.
Article in English, Italian | MEDLINE | ID: mdl-23715202

ABSTRACT

Atypical odontalgia (AO) is a little known chronic pain condition. It usually presents as pain in a site where a tooth was endodontically treated or extracted, in the absence of clinical or radiographic evidence of tooth pathology. It is a rare clinical challenge for most clinicians, which leads to the patients being referred to several specialists and sometimes undergoing unnecessary surgical procedures. The pain mechanisms involved in AO are far from clear, and numerous potential mechanisms have been suggested. Currently, the most accredited hypothesis is that AO is a neuropathic pain condition caused by deafferentation. The differential diagnosis of AO remains difficult, because it shares symptoms with many others pathologies affecting this area. Patients have difficulties accepting the AO diagnosis and treatment. As a result, they frequently change physicians, and may potentially also receive several invasive treatments, usually resulting in an aggravation of the pain. Although some patients do get complete pain relief following treatment, for most patients the goal should be to achieve adequate pain management. Currently, most management is based on expert opinion and case reports. More research and high quality randomized controlled trials are needed in order to develop evidence-based treatments, currently based on expert opinion or carried over from other neuropathic pain conditions in the orofacial region.


Subject(s)
Toothache/physiopathology , Adult , Analgesics/therapeutic use , Anesthetics, Local/therapeutic use , Antidepressive Agents, Tricyclic/therapeutic use , Calcium Channel Blockers/therapeutic use , Causalgia/drug therapy , Causalgia/etiology , Causalgia/physiopathology , Child , Dental Pulp Diseases/diagnosis , Diagnosis, Differential , Diagnostic Imaging , Female , Humans , Male , Models, Neurological , Oral Surgical Procedures/adverse effects , Pain, Postoperative/etiology , Patient Acceptance of Health Care , Phantom Limb/drug therapy , Phantom Limb/etiology , Phantom Limb/physiopathology , Physical Examination/methods , Randomized Controlled Trials as Topic , Temporomandibular Joint Disorders/diagnosis , Tooth Injuries/complications , Toothache/diagnosis , Toothache/drug therapy , Toothache/etiology , Toothache/psychology , Unnecessary Procedures
15.
Minerva Stomatol ; 61(11-12): 467-76, 2012.
Article in English, Italian | MEDLINE | ID: mdl-23207672

ABSTRACT

AIM: In Italy there is about one undiagnosed case of diabetes for each known case. The dental office might represent an important setting for screening the glycemic status of patients. The aim of the present study was to evaluate the effectiveness of dental chair-side capillary blood sampling for the identification of undiagnosed hyperglycemia in a group of Italian patients. METHODS: Five hundred fifteen patients >45 years old consecutively visiting a public university dental clinic, where admission is regulated by medical or income criteria, were considered for the study. Demographic data, medical history, time of the last caloric intake and waist width were recorded for each participant. All participants underwent an oral examination. Glycemic values were obtained by capillary blood glucose testing. RESULTS: Of the 400 subjects who took part in the study, a low percentage of unaware diabetic individuals (1.7%) was identified. Inclusion criteria restriction to subjects between 50 and 75 years of age and a waist circumference >92 cm would have resulted in a proportion of diabetic patients of 4.3%. CONCLUSION: Dental chair-side in a public university clinic in Italy failed to disclose the expected number of unaware diabetic patients.


Subject(s)
Dental Offices , Diabetes Mellitus/diagnosis , Aged , Aged, 80 and over , Female , Humans , Italy , Male , Middle Aged , Pilot Projects , Prospective Studies , Universities
16.
Curr Med Chem ; 19(11): 1706-20, 2012.
Article in English | MEDLINE | ID: mdl-22376030

ABSTRACT

Despite the protective role of diets rich in fruit plant polyphenols against some cancers and chronic degenerative and inflammatory diseases, insufficient emphasis has been placed on oral health. Numerous studies have aimed to ascertain the role of polyphenols in the prevention and treatment of oral diseases; however, even when in vitro evidence appears convincing, the same is not true for in vivo studies, and thus there is a general paucity of solid evidence based on animal and clinical trials. To the best of our knowledge, only two reviews of polyphenols and oral health have been published; however, neither considered the potential role of whole plant extracts, which contain mixtures of many polyphenols that are often not completely identified. In the present study, our main aim was to review the current state of knowledge (search period: January 1965 to March 2011) on the effects of plant extracts/polyphenols on oral health. We found data on grapes, berries, tea, cocoa, coffee, myrtle, chamomile, honey/propolis, aloe extracts and the three main groups of polyphenols (stilbenes, flavonoids and proanthocyanidins). Their effects on caries, gingivitis, periodontal disease, candidiasis, oral aphtae, oral mucositis, oral lichen planus, leukoplakia and oral cancer were investigated. The data suggest that there is a lack of strong evidence, in particular regarding randomized clinical trials. However, a fascinating starting point has been provided by pre-clinical studies that have shown interesting activities of polyphenols against the most common oral diseases (caries, periodontitis and candidiasis), as well as in oral cancer prevention.


Subject(s)
Mouth Diseases/drug therapy , Mouth Diseases/prevention & control , Oral Health , Plant Extracts/therapeutic use , Polyphenols/therapeutic use , Animals , Humans , Phytotherapy , Plant Extracts/chemistry , Plant Extracts/pharmacology , Polyphenols/biosynthesis , Polyphenols/chemistry , Polyphenols/pharmacology
17.
Eur Respir J ; 38(6): 1287-93, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21565920

ABSTRACT

Noninvasive biomarkers can be used to evaluate airways damage caused by tobacco smoke, but studies so far have only involved adult smokers. In this study, we evaluated whether such biomarkers can detect early respiratory effects in adolescents passively or actively exposed to tobacco smoke. In a cross-sectional study of 845 adolescents (mean age 16 yrs), we measured exhaled nitric oxide (NO) and various epithelial markers in nasal lavage fluid (NALF) and serum, including Clara cell protein (CC16) and surfactant protein (SP)-D. Information about smoking habits and potential confounders was collected by questionnaire. Four groups of equal size (n = 36), of nonsmokers, passive smokers, light smokers (<5 cigarettes · day(-1), median 0.08 pack-yrs) and heavy smokers (≥ 5 cigarettes · day(-1), median 0.35 pack-yrs), were matched using an automated procedure. The levels of exhaled NO and of CC16 in NALF were significantly decreased in the group of heavy smokers. A trend towards lower levels of CC16 in NALF was observed in passive smokers. There were no significant changes in serum CC16 and SP-D, which suggests that the deep lung epithelium had not yet been affected by smoking. In conclusion, tobacco smoke can cause early changes in the airways of adolescents with a cumulative smoking history of <1 pack-yr.


Subject(s)
Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/physiopathology , Smoking/adverse effects , Tobacco Smoke Pollution/adverse effects , Adolescent , Biomarkers/analysis , Biomarkers/metabolism , Breath Tests , Cross-Sectional Studies , Female , Humans , Lung/physiopathology , Male , Nasal Lavage Fluid/chemistry , Nitric Oxide/analysis , Pulmonary Surfactant-Associated Protein D/analysis , Smoking/blood , Smoking/metabolism , Uteroglobin/analysis
18.
Eur Respir J ; 36(1): 41-7, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20075053

ABSTRACT

Recent studies suggest that swimming in chlorinated pools during infancy may increase the risks of lower respiratory tract infection. The aim of the present study was to assess the influence of swimming in chlorinated pools on the risks of bronchiolitis and its late consequences. A total of 430 children (47% female; mean age 5.7 yrs) in 30 kindergartens were examined. Parents completed a questionnaire regarding the child's health history, swimming practice and potential confounders. Attendance at indoor or outdoor chlorinated pools ever before the age of 2 yrs was associated with an increased risk of bronchiolitis (OR 1.68; 95% CI 1.08-2.68; p = 0.03), which was exposure-dependent for both types of pool (p-value for trend <0.01). Associations persisted, and were even strengthened, by the exclusion of other risk factors. Among children with no parental antecedents of atopic disease or no day-care attendance, odds ratios for bronchiolitis amounted to 4.45 (1.82-10.9; p = 0.001) and 4.44 (1.88-10.5; p = 0.007) after >20 h spent in chlorinated pools during infancy. Infant swimmers who developed bronchiolitis also showed higher risks of asthma and respiratory allergies later in childhood. Swimming pool attendance during infancy is associated with a higher risk of bronchiolitis, with ensuing increased risks of asthma and allergic sensitisation.


Subject(s)
Asthma/epidemiology , Bronchiolitis/epidemiology , Chlorine/adverse effects , Disinfectants/adverse effects , Hypersensitivity/epidemiology , Swimming Pools , Swimming , Asthma/etiology , Belgium/epidemiology , Bronchiolitis/etiology , Child , Child, Preschool , Female , Humans , Hypersensitivity/etiology , Infant , Male , Prospective Studies , Risk Factors
19.
Oral Dis ; 16(1): 61-7, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19732355

ABSTRACT

BACKGROUND: Survivin is involved in modulation of cell death and cell division processes. Survivin expression in normal adult tissues has not been fully understood, although it is markedly lower than in cancer, where it is over-expressed. OBJECTIVE: To investigate survivin expression in normal, potentially malignant and cancerous oral mucosa. METHODS: We measured survivin mRNA levels by real-time RT-PCR in specimens of oral mucosa (15 from normal mucosa, 17 from potentially malignant lesions, 17 from neoplasms). Scores were compared using Kruskal-Wallis test and post hoc according to Conover. Chi-squared test was used for dichotomous data. RESULTS: The median relative levels of survivin mRNA resulted six for normal mucosa, eight for potentially malignant lesions, 13 for cancers: differences among these three groups were statistically significant, as between cancer and potentially malignant lesions. Expression in normal mucosa and potentially lesions group showed no significant difference. Low, but not marginal expression of survivin in normal mucosa is a new finding, and it could be explained with the higher sensibility of our methods. CONCLUSIONS: Survivin expression in oral potentially malignant lesions might indicate a progressive deregulation of expression paralleling oncogenesis, particularly during the first stages of process, suggesting a putative predictive role for survivin.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Leukoplakia, Oral/metabolism , Microtubule-Associated Proteins/biosynthesis , Mouth Mucosa/metabolism , Mouth Neoplasms/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/chemistry , Case-Control Studies , Chi-Square Distribution , Female , Humans , Inhibitor of Apoptosis Proteins , Leukoplakia, Oral/chemistry , Male , Middle Aged , Mouth Mucosa/chemistry , Mouth Neoplasms/chemistry , Prognosis , RNA, Messenger/analysis , RNA, Neoplasm/analysis , Reverse Transcriptase Polymerase Chain Reaction , Smoking/metabolism , Statistics, Nonparametric , Survivin , Young Adult
20.
Minerva Stomatol ; 58(6): 289-99, 2009 Jun.
Article in English, Italian | MEDLINE | ID: mdl-19516237

ABSTRACT

Previously called atypical facial pain, persistent idiopathic facial pain (PIFP) is a common, but poorly defined entity. The cause of PIFP is unknown, but surgery or injury in the distribution of the trigeminal nerve could be reported as early event. Treatment is often unsatisfactory and quality research relating management of this condition is missing. Psychologi-cal distress is frequently observed in patients suffering from persistent idiopathic facial pain. The present review aims at presenting the available knowledge of this elusive orofacial pain condition.


Subject(s)
Facial Neuralgia , Adaptation, Psychological , Analgesics/therapeutic use , Antidepressive Agents/therapeutic use , Clinical Trials as Topic , Counseling , Cross-Over Studies , Depression/complications , Emotions , Face/innervation , Facial Neuralgia/epidemiology , Facial Neuralgia/etiology , Facial Neuralgia/physiopathology , Facial Neuralgia/psychology , Facial Neuralgia/therapy , Female , Humans , Male , Mouth/innervation , Nociceptors/physiology , Positron-Emission Tomography , Putamen/diagnostic imaging , Putamen/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...